Cargando…
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089297/ https://www.ncbi.nlm.nih.gov/pubmed/35538168 http://dx.doi.org/10.1007/s00415-022-11152-5 |
| _version_ | 1784704485796347904 |
|---|---|
| author | Huo, Shufan Ferse, Caroline Bösl, Fabian Reincke, S. Momsen Enghard, Philipp Hinrichs, Carl Treskatsch, Sascha Angermair, Stefan Eckardt, Kai-Uwe Audebert, Heinrich J. Ploner, Christoph J. Endres, Matthias Prüss, Harald Franke, Christiana Scheibe, Franziska |
| author_facet | Huo, Shufan Ferse, Caroline Bösl, Fabian Reincke, S. Momsen Enghard, Philipp Hinrichs, Carl Treskatsch, Sascha Angermair, Stefan Eckardt, Kai-Uwe Audebert, Heinrich J. Ploner, Christoph J. Endres, Matthias Prüss, Harald Franke, Christiana Scheibe, Franziska |
| author_sort | Huo, Shufan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9089297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90892972022-05-10 Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy Huo, Shufan Ferse, Caroline Bösl, Fabian Reincke, S. Momsen Enghard, Philipp Hinrichs, Carl Treskatsch, Sascha Angermair, Stefan Eckardt, Kai-Uwe Audebert, Heinrich J. Ploner, Christoph J. Endres, Matthias Prüss, Harald Franke, Christiana Scheibe, Franziska J Neurol Letter to the Editors Springer Berlin Heidelberg 2022-05-10 2022 /pmc/articles/PMC9089297/ /pubmed/35538168 http://dx.doi.org/10.1007/s00415-022-11152-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editors Huo, Shufan Ferse, Caroline Bösl, Fabian Reincke, S. Momsen Enghard, Philipp Hinrichs, Carl Treskatsch, Sascha Angermair, Stefan Eckardt, Kai-Uwe Audebert, Heinrich J. Ploner, Christoph J. Endres, Matthias Prüss, Harald Franke, Christiana Scheibe, Franziska Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title | Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title_full | Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title_fullStr | Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title_full_unstemmed | Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title_short | Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy |
| title_sort | intravenous immunoglobulins for treatment of severe covid-19-related acute encephalopathy |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089297/ https://www.ncbi.nlm.nih.gov/pubmed/35538168 http://dx.doi.org/10.1007/s00415-022-11152-5 |
| work_keys_str_mv | AT huoshufan intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT fersecaroline intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT boslfabian intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT reinckesmomsen intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT enghardphilipp intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT hinrichscarl intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT treskatschsascha intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT angermairstefan intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT eckardtkaiuwe intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT audebertheinrichj intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT plonerchristophj intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT endresmatthias intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT prussharald intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT frankechristiana intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy AT scheibefranziska intravenousimmunoglobulinsfortreatmentofseverecovid19relatedacuteencephalopathy |